SUI is one of the few altcoins resilient to recent downturns, holding steady for the week with a 0.5% gain—making its claim ...

Trump’s new tariffs, falling rate cut odds, and a looming bear flag breakdown threaten to erase crypto gains from the 2024 ...

ArcBest shows resilience with strong customer retention despite weaker Q4 2024. See why ARCB stock offers a solid buy ...

AbbVie is grappling with diminishing Humira sales and is also trading at an above-average P/E. See why I rate ABBV stock as a ...

XRP currently trades around $2.05 with analysts predicting a potential rise to $5-$27 in the coming months based on technical ...

The SEC could officially announce that it will drop its ongoing legal battle against Ripple today. Will XRP explode?

Analysts assess the potential impact of US tariffs on Singapore's economy, considering both challenges and potential ...

Aritzia Inc. (TSE:ATZ) has recently captured significant investor attention due to notable fluctuations in its stock price. Trading at highs of CA$72.57 and lows of CA$50.22 within a few months, this ...

A total of 29 new blockbuster-in-waiting drugs entered the late-stage pipeline in 2024, a jump from the previous year’s 19.

Mobility data offers a powerful solution by providing deep insights into customer engagement and competitive positioning.

Offshore rig market faces a challenging year ahead, with falling dayrates and weak demand amid contract suspensions and ...

Shiba Inu holds the largest market capitalization among all the memecoins, but we now see more enhanced memecoins offering ...